CY1108207T1 - Στοματικη παροχη φαρμακων - Google Patents

Στοματικη παροχη φαρμακων

Info

Publication number
CY1108207T1
CY1108207T1 CY20081100761T CY081100761T CY1108207T1 CY 1108207 T1 CY1108207 T1 CY 1108207T1 CY 20081100761 T CY20081100761 T CY 20081100761T CY 081100761 T CY081100761 T CY 081100761T CY 1108207 T1 CY1108207 T1 CY 1108207T1
Authority
CY
Cyprus
Prior art keywords
lozenge
medicines
oral delivery
stable
crystallising sugar
Prior art date
Application number
CY20081100761T
Other languages
English (en)
Inventor
Anders Dam
Janos Major
Peter Tasko
Original Assignee
Arrow No.7 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arrow No.7 Ltd filed Critical Arrow No.7 Ltd
Publication of CY1108207T1 publication Critical patent/CY1108207T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Παρέχεται μια παστίλια η οποία έχει ένα σταθερό pΗ και σταθερά επίπεδα δραστικού συστατικού κατά τη διάρκεια του χρόνου. Αυτή περιλαμβάνει ένα συνδυασμό από (i) τουλάχιστον ένα κόμμι και (ii) τουλάχιστον ένα σάκχαρο που δεν κρυσταλλώνεται ή μια αλκοόλη σακχάρου που δεν κρυσταλλώνεται σε μια μήτρα που προορίζεται για ελεγχόμενη στοματική παροχή ενός φαρμάκου. Η παστίλια περιέχει επίσης νερό και προαιρετικά συστατικά που επιλέγονται από αρωματικές ουσίες, παράγοντες που συγκαλύπτουν τη γεύση, χρωστικές ουσίες, συστατικά ρυθμιστικού διαλύματος, παράγοντες προσαρμογής pΗ, έκδοχα, σταθεροποιητές και γλυκαντικές ουσίες. Παρέχονται επίσης μέθοδοι για την παρασκευή της παστίλιας.
CY20081100761T 2003-09-05 2008-07-21 Στοματικη παροχη φαρμακων CY1108207T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0320854.3A GB0320854D0 (en) 2003-09-05 2003-09-05 Buccal drug delivery
GBGB0403373.4A GB0403373D0 (en) 2003-09-05 2004-02-16 Buccal drug delivery
EP04768358A EP1667662B1 (en) 2003-09-05 2004-09-06 Buccal drug delivery

Publications (1)

Publication Number Publication Date
CY1108207T1 true CY1108207T1 (el) 2014-02-12

Family

ID=34276828

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100761T CY1108207T1 (el) 2003-09-05 2008-07-21 Στοματικη παροχη φαρμακων

Country Status (22)

Country Link
US (4) US8343532B2 (el)
EP (2) EP1938806A1 (el)
JP (2) JP5303111B2 (el)
CN (1) CN1845724B (el)
AT (1) ATE392888T1 (el)
AU (1) AU2004269968B2 (el)
BR (1) BRPI0414178A (el)
CA (1) CA2537797C (el)
CY (1) CY1108207T1 (el)
DE (1) DE602004013348T2 (el)
DK (1) DK1667662T3 (el)
ES (1) ES2305842T3 (el)
GB (2) GB0320854D0 (el)
HR (1) HRP20080289T3 (el)
IL (1) IL173998A0 (el)
NO (1) NO20061525L (el)
NZ (1) NZ545673A (el)
PL (1) PL1667662T3 (el)
PT (1) PT1667662E (el)
SI (1) SI1667662T1 (el)
WO (1) WO2005023226A1 (el)
ZA (1) ZA200601902B (el)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0320854D0 (en) * 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
KR101474871B1 (ko) * 2006-05-23 2014-12-19 오라헬쓰 코포레이션 아카시아 껌 접착제를 갖는 2층 구강 접착 정제
GB2468424B (en) * 2007-04-02 2011-11-09 Parkinson S Inst Methods and compositions for reduction of side effects of therapeutic treatments
GB2453770A (en) * 2007-10-19 2009-04-22 Reckitt Benckiser Healthcare Oral composition comprising a cooling agent
MX2010010607A (es) 2008-03-26 2011-03-29 Stichting Sanammad Composiciones para goma de mascar que comprenden canabinoides.
AR071420A1 (es) * 2008-05-01 2010-06-16 Smithkline Beecham Corp Composicion de pastilla para chupar oral que comprende un principio activo de nicotina y procedimiento para fabricarla
EP2437730A4 (en) * 2009-05-20 2014-02-26 Lingual Consegna Pty Ltd ORAL AND / OR SUBLINGUAL THERAPEUTIC FORMULATION
GB0920041D0 (en) * 2009-11-16 2009-12-30 Univ Aston Tablet
US9775376B2 (en) * 2010-12-01 2017-10-03 R.J. Reynolds Tobacco Company Smokeless tobacco pastille and moulding process for forming smokeless tobacco products
KR101274779B1 (ko) * 2010-12-08 2013-06-25 주식회사 삼양제넥스 당 코팅 차전자피 함유 분말 조성물
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US20130177646A1 (en) * 2012-01-05 2013-07-11 Mcneil Ab Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9789061B2 (en) * 2012-02-19 2017-10-17 Orahealth Corp. Acacia gum adhesive with calcium carbonate for oral adhering discs
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
US10555952B2 (en) 2015-06-19 2020-02-11 Melt Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
KR101964571B1 (ko) * 2015-06-19 2019-04-02 해로우 헬스 인코포레이티드 마취용 약학 조성물
US10391102B2 (en) 2015-06-19 2019-08-27 Melt Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
US20200297734A1 (en) 2015-06-19 2020-09-24 Melt Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
EP4268815A3 (en) 2019-04-17 2024-02-21 NordicCan A/S Fast disintegrating cannabinoid tablets
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US11889856B2 (en) 2019-12-09 2024-02-06 Nicoventures Trading Limited Oral foam composition
CA3160750A1 (en) 2019-12-09 2021-06-17 Anthony Richard Gerardi Oral product comprising a cannabinoid
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US11883527B2 (en) 2019-12-09 2024-01-30 Nicoventures Trading Limited Oral composition and method of manufacture
US11672862B2 (en) 2019-12-09 2023-06-13 Nicoventures Trading Limited Oral products with reduced irritation
CA3168632A1 (en) * 2020-01-30 2021-08-05 Purcann Pharma Inc. Method for preventing or reducing cannabaceae biomass decomposition
US11839602B2 (en) 2020-11-25 2023-12-12 Nicoventures Trading Limited Oral cannabinoid product with lipid component
WO2024097549A1 (en) * 2022-11-03 2024-05-10 Nic Nac Naturals, Llc Composition and method for controlled human nicotine absorption without ph adjusters
CN116114905A (zh) * 2023-02-09 2023-05-16 东莞市吉纯生物技术有限公司 一种具有保湿功能的口含制品及其制备方法和应用

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1571522A1 (de) 1966-12-16 1970-07-23 Gebefuegi Dipl Ing Istvan Verfahren und Herstellung von Formkoerpern fuer Bauund Isolierzwecke aus geblaehtem Perlit oder Vermikulit
US3590117A (en) 1969-03-24 1971-06-29 Richardson Merrell Inc Long-lasting troche containing guar gum
GB2049417B (en) 1979-05-29 1983-06-15 Mitra A K Extended release antiacid lozenges
US4614654A (en) 1984-08-24 1986-09-30 Wm. Wrigley Jr. Company Taffy-like chewing gum confection and method
DK161428C (da) 1985-05-10 1991-12-16 Fertin Lab As Fast, oralt cariesmodvirkende middel
IT1191674B (it) 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
GB8608818D0 (en) 1986-04-11 1986-05-14 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
JPS62298528A (ja) * 1986-06-16 1987-12-25 Yutaka Mizushima 咽頭痛治療トロ−チ
JP2522772B2 (ja) 1986-08-19 1996-08-07 太陽誘電株式会社 Ｗをド―プしたＴｉＯ２単結晶粒子とその製造方法
US5525351A (en) * 1989-11-07 1996-06-11 Dam; Anders Nicotine containing stimulant unit
DK615689A (da) 1989-11-07 1991-05-08 Anders Dam Rygesupplement eller rygeerstatningsprodukt
US5156845A (en) 1990-05-04 1992-10-20 Colgate-Palmolive Company Dry mouth lozenge
US5549906A (en) 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
CA2178733C (en) * 1993-12-29 1999-02-16 Pamela M. Mazurek Liquid sorbitol/mannitol/glycerin blend and compositions containing same
US5651936A (en) * 1993-12-29 1997-07-29 Wm. Wrigley Jr. Company Syrups containing sorbitol, a plasticizing agent and an anticrystallization agent and their use in chewing gum and other products
MA23587A1 (fr) 1994-06-23 1995-12-31 Procter & Gamble Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme
IN182040B (el) 1995-06-13 1998-12-12 American Home Prod
US5762961A (en) * 1996-02-09 1998-06-09 Quadrant Holdings Cambridge Ltd. Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
DE19606968C2 (de) 1996-02-24 1998-07-09 Suedzucker Ag Verwendung von 1,1-GPS in Hartkaramellen
TR199802068T2 (xx) 1996-04-16 2000-01-21 Novartis Consumer Health S.A. H�zl� b�l�nen oral doz formu.
JP3707798B2 (ja) 1996-05-13 2005-10-19 ノバルティス・コンシューマー・ヘルス・ソシエテ・アノニム 口内薬剤輸送系
US5939091A (en) 1997-05-20 1999-08-17 Warner Lambert Company Method for making fast-melt tablets
US8293277B2 (en) * 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
JP2002538102A (ja) * 1999-03-01 2002-11-12 セプラコア インコーポレーテッド 光学的に純粋なｒ（＋）オンダンセトロンを使用する無呼吸および無呼吸障害の治療方法
GB2352051A (en) * 1999-07-14 2001-01-17 Taiko Denki Co Ltd Two part cable connectors
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
WO2001037814A1 (en) 1999-11-23 2001-05-31 Robert Gordon University Bilayered buccal tablets comprising nicotine
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
JP2004525928A (ja) 2001-03-26 2004-08-26 スミスクライン・ビーチャム・コーポレイション ニコチン含有経口剤形
CA2449415A1 (en) 2001-04-20 2002-10-31 Lavipharm Laboratories Inc. Intraoral delivery of nicotine for smoking cessation
US20040062804A1 (en) * 2001-09-28 2004-04-01 Der-Yang Lee Modified release dosage forms
US20040037879A1 (en) 2001-11-02 2004-02-26 Adusumilli Prasad S. Oral controlled release forms useful for reducing or preventing nicotine cravings
US20040101543A1 (en) 2002-03-22 2004-05-27 John Liu Nicotine-containing oral dosage form
US20030185884A1 (en) * 2002-04-01 2003-10-02 Singh Nikhilesh Nihala Therapeutic agent delivery compositions for buccal cavity absorption of pilocarpine
UA79281C2 (en) * 2002-04-03 2007-06-11 Solvay Pharm Bv Stabilized composition comprising a natural cannabinoid compound and process for the preparation thereof
US20040052851A1 (en) * 2002-09-16 2004-03-18 Graff Allan H. Modified release oral dosage form
GB0320854D0 (en) * 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery

Also Published As

Publication number Publication date
EP1667662B1 (en) 2008-04-23
AU2004269968B2 (en) 2009-11-12
ATE392888T1 (de) 2008-05-15
GB0320854D0 (en) 2003-10-08
US8343532B2 (en) 2013-01-01
US20140054826A1 (en) 2014-02-27
PT1667662E (pt) 2008-07-15
CA2537797C (en) 2011-10-25
GB0403373D0 (en) 2004-03-17
HRP20080289T3 (en) 2008-08-31
JP2013064005A (ja) 2013-04-11
CA2537797A1 (en) 2005-03-17
JP2007504207A (ja) 2007-03-01
CN1845724B (zh) 2015-05-13
NZ545673A (en) 2009-03-31
SI1667662T1 (sl) 2008-10-31
PL1667662T3 (pl) 2008-10-31
WO2005023226A1 (en) 2005-03-17
EP1667662A1 (en) 2006-06-14
ZA200601902B (en) 2007-09-26
DK1667662T3 (da) 2008-08-25
IL173998A0 (en) 2006-07-05
EP1938806A1 (en) 2008-07-02
US20130085165A1 (en) 2013-04-04
US8603516B2 (en) 2013-12-10
JP5303111B2 (ja) 2013-10-02
NO20061525L (no) 2006-06-06
ES2305842T3 (es) 2008-11-01
US8603517B2 (en) 2013-12-10
CN1845724A (zh) 2006-10-11
US20130087946A1 (en) 2013-04-11
BRPI0414178A (pt) 2006-10-31
DE602004013348T2 (de) 2009-11-19
DE602004013348D1 (de) 2008-06-05
US8858984B2 (en) 2014-10-14
AU2004269968A1 (en) 2005-03-17
US20070081949A1 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
CY1108207T1 (el) Στοματικη παροχη φαρμακων
DK1082106T3 (da) Brusemiddeltablet til sublingual, bukkal og gingival administration af fentanyl
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
NO20063430L (no) Generelt lineaer, brusende oral fentanyl doseringsform, og metoder for administrering
NO20061245L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og en bisfosfon
NO20053224D0 (no) Patient controlled drug administration device.
BR0208382A (pt) Forma de dosagem oral contendo nicotina
IS8885A (is) Lyfjablanda á föstu formi til til inntöku sem felur í sér S1P viðtakaörva og sykuralkóhól
IL176452A0 (en) Effervescent oral opiate dosage form
IS6892A (is) Lyfjasamsetningar, skammtaform og aðferðir til aðgefa epóþílon um munn
NO20061236L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton
ATE354362T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
WO2005018605A3 (en) Novel formulation of ropinirole
WO2006020522A3 (en) Multiplex drug delivery device
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
NO20062668L (no) Orale formuleringer av desoxypeganin og anvendelser derav
SE0203817D0 (sv) New composition
UA91824C2 (ru) Преимущественно линейная шипучая лекарственная форма фентанила для перорального применения и способы введения
TH67944A (th) ยาเม็ดชนิดเคี้ยวได้ที่น่ารับประทาน